Bain Capital Life Sciences Fund II, L.P.

Holdings History for Xilio Therapeutics, Inc. - Common Stock, par value $0.0001 per share (XLO)

Symbol: XLO on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 6,259,742 shares
Security Ownership %: 8.5%

BCLS II Equity Opportunities, LP ownership in Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share (XLO)

17 Feb 2026 - BCLS II Equity Opportunities, LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,259,742 shares of Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share (XLO). This represents 8.5% ownership of the company. This is the first filing by Bain Capital Life Sciences Fund II, L.P. disclosing ownership of Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share (XLO).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
BCLS II Equity Opportunities, LP	8.5%		$4,131,430	6,259,742			$0.66	13G/A	31 Dec 2025	17 Feb 2026, 16:30